500 related articles for article (PubMed ID: 9474472)
21. Pharmacokinetic variability of beta-lactams in critically ill patients: A narrative review.
Boidin C; Moshiri P; Dahyot-Fizelier C; Goutelle S; Lefeuvre S
Anaesth Crit Care Pain Med; 2020 Feb; 39(1):87-109. PubMed ID: 31513935
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetic Alterations Associated with Critical Illness.
Morales Castro D; Dresser L; Granton J; Fan E
Clin Pharmacokinet; 2023 Feb; 62(2):209-220. PubMed ID: 36732476
[TBL] [Abstract][Full Text] [Related]
23. Sedative and neuromuscular blocking drug use in critically ill patients with head injuries.
Prielipp RC; Coursin DB
New Horiz; 1995 Aug; 3(3):456-68. PubMed ID: 7496755
[TBL] [Abstract][Full Text] [Related]
24. Clinical pharmacokinetic monitoring of midazolam in critically ill patients.
Spina SP; Ensom MH
Pharmacotherapy; 2007 Mar; 27(3):389-98. PubMed ID: 17316150
[TBL] [Abstract][Full Text] [Related]
25. [Personalised pharmacotherapy in intensive care unit patients].
Bellmann R
Med Klin Intensivmed Notfmed; 2017 May; 112(4):289-294. PubMed ID: 28466289
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetic issues for antibiotics in the critically ill patient.
Roberts JA; Lipman J
Crit Care Med; 2009 Mar; 37(3):840-51; quiz 859. PubMed ID: 19237886
[TBL] [Abstract][Full Text] [Related]
27. Clinical Practice Guidelines for Sustained Neuromuscular Blockade in the Adult Critically Ill Patient.
Murray MJ; DeBlock H; Erstad B; Gray A; Jacobi J; Jordan C; McGee W; McManus C; Meade M; Nix S; Patterson A; Sands MK; Pino R; Tescher A; Arbour R; Rochwerg B; Murray CF; Mehta S
Crit Care Med; 2016 Nov; 44(11):2079-2103. PubMed ID: 27755068
[TBL] [Abstract][Full Text] [Related]
28. Semi-mechanistic autoinduction model of midazolam in critically ill patients: population pharmacokinetic analysis.
Aoyama T; Hirata K; Yamamoto Y; Yokota H; Hayashi H; Aoyama Y; Matsumoto Y
J Clin Pharm Ther; 2016 Aug; 41(4):392-8. PubMed ID: 27178380
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetic/pharmacodynamic considerations for the optimization of antimicrobial delivery in the critically ill.
Tsai D; Lipman J; Roberts JA
Curr Opin Crit Care; 2015 Oct; 21(5):412-20. PubMed ID: 26348420
[TBL] [Abstract][Full Text] [Related]
30. Sedation in the critically ill patient.
Costa MG; Chiarandini P; Della Rocca G
Transplant Proc; 2006 Apr; 38(3):803-4. PubMed ID: 16647476
[TBL] [Abstract][Full Text] [Related]
31. Introduction to drug pharmacokinetics in the critically ill patient.
Smith BS; Yogaratnam D; Levasseur-Franklin KE; Forni A; Fong J
Chest; 2012 May; 141(5):1327-1336. PubMed ID: 22553267
[TBL] [Abstract][Full Text] [Related]
32. Drug dosing in continuous renal replacement therapy: general rules.
Schetz M
Curr Opin Crit Care; 2007 Dec; 13(6):645-51. PubMed ID: 17975384
[TBL] [Abstract][Full Text] [Related]
33. [Analgesia and sedation in intensive care patients].
Radke J
Anaesthesist; 1992 Dec; 41(12):793-808. PubMed ID: 1489080
[TBL] [Abstract][Full Text] [Related]
34. How can we ensure effective antibiotic dosing in critically ill patients receiving different types of renal replacement therapy?
Jamal JA; Mueller BA; Choi GY; Lipman J; Roberts JA
Diagn Microbiol Infect Dis; 2015 May; 82(1):92-103. PubMed ID: 25698632
[TBL] [Abstract][Full Text] [Related]
35. Perioperative Pharmacologic Management of Patients with End Stage Renal Disease.
Karambelkar A; Kasekar R; Palevsky PM
Semin Dial; 2015; 28(4):392-6. PubMed ID: 25876523
[TBL] [Abstract][Full Text] [Related]
36. Bioavailability of gatifloxacin by gastric tube administration with and without concomitant enteral feeding in critically ill patients.
Kanji S; McKinnon PS; Barletta JF; Kruse JA; Devlin JW
Crit Care Med; 2003 May; 31(5):1347-52. PubMed ID: 12771601
[TBL] [Abstract][Full Text] [Related]
37. [Pharmacokinetics of antibiotics in obese and critical care patients].
Stahlmann R; Lode H
Dtsch Med Wochenschr; 2015 Feb; 140(4):271-6. PubMed ID: 25704524
[TBL] [Abstract][Full Text] [Related]
38. Optimal doripenem dosing simulations in critically ill nosocomial pneumonia patients with obesity, augmented renal clearance, and decreased bacterial susceptibility.
Roberts JA; Lipman J
Crit Care Med; 2013 Feb; 41(2):489-95. PubMed ID: 23263583
[TBL] [Abstract][Full Text] [Related]
39. Clinical Pharmacology Studies in Critically Ill Children.
Thakkar N; Salerno S; Hornik CP; Gonzalez D
Pharm Res; 2017 Jan; 34(1):7-24. PubMed ID: 27585904
[TBL] [Abstract][Full Text] [Related]
40. The effect of pathophysiology on pharmacokinetics in the critically ill patient--concepts appraised by the example of antimicrobial agents.
Blot SI; Pea F; Lipman J
Adv Drug Deliv Rev; 2014 Nov; 77():3-11. PubMed ID: 25038549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
